Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global ENT devices market was valued at US$ 23.00 billion in 2022 and is expected to register a revenue CAGR of 6.3% to reach US$ 39.86 billion by 2031.

ENT Devices Market Fundamentals 

ENT devices are specialized instruments used to diagnose and treat conditions affecting the ear, nose, and throat. Ear infections, sinus, apnea, and tonsillitis are some common ENT conditions that affect people. The ENT devices include, among other things, tongue depressors, tonsils forceps, voice prostheses, hearing aids, and endoscopes. These devices have transformed many ENT diseases' diagnosis, therapy, and management. ENT equipment, which ranges from endoscopes to hearing aids, is crucial for boosting diagnostic precision, enhancing patient outcomes, and delivering efficient treatment interventions. The use and importance of ENT devices in contemporary healthcare are examined in this essay.

The most well-known and often-used ENT devices are hearing aids. They are made to help those who have hearing loss by boosting sound and improving speech understanding. Modern hearing aids use digital signal processing technology, allowing for customization by the user's unique hearing requirements. They may be modified to account for various degrees and types of hearing loss, restoring people's quality of life and enabling full participation in social activities. Furthermore, when conventional hearing aids may not be helpful due to severe to profound hearing loss, cochlear implants are extremely complex medical devices that are employed. A surgically inserted internal devices array and an external processor comprise the two primary parts of these implants. The auditory nerve is stimulated directly via cochlear implants, allowing users to hear sound impulses without going around damaged or non-functioning inner ear tissue. This technology has transformed the lives of many people with substantial hearing loss by allowing them to communicate and enjoy a world of sound successfully.

ENT Devices Market Dynamics

Hearing loss or impairment is one of the most prevalent medical disorders, especially in developed nations. The WHO estimates that over 460 million individuals, or about 5% of the world's population, currently have incapacitating hearing loss. By 2050, that number will rise to over 900 million, or one in every ten people. Growing life expectancy and an increase in noise pollution, which increases in cases of hearing loss due to aging, are two primary causes. In low-income nations, infections, including measles, middle ear infections, and meningitis, are also frequent causes of hearing loss. Furthermore, hearing loss may be brought on by long-term inflammation, noise exposure, vascular issues, physiologic aging of the ear, and genetic vulnerability.

Emerging technologies like AI and ML and developments in auditory goods are boosting the industry's growth. For instance, the AI hearing aid Arc-AI was introduced by the health technology company Audibel in October 2021. It is available in various forms, including behind-the-ear and fully in-canal types. It is designed to change hearing levels automatically and lively introduced an online audiology platform in January 2019 that offers all clients hearing aids, testing, and 24/7 online assistance. Without going to a clinic or retail location, all platform users may connect with an audiologist through video conference and get hearing aids.

The market for ENT devices is expected to increase primarily due to technical improvements, the rising use of less invasive ENT treatments, and the rising prevalence of ENT-related ailments. One of the medical disorders known as sinusitis is characterized by prolonged inflammation or swelling of the sinus cavities surrounding the nasal passages. Odontogenic sinusitis costs approximately USD 6 billion annually in the United States, plus USD 2 billion for over-the-counter medications, with a prevalence rate of 10.4% in Europe and 14.0% in the United States, according to a study titled "Odontogenic Sinusitis: From Diagnosis to Treatment Possibilities—A Narrative Review of Recent Data" published in the MDPI Diagnosis. Additionally, more than 0.5 million operations are performed annually to treat chronic sinusitis.

ENT Devices Market Ecosystem

The global ENT devices market is analyzed from the following perspectives by product, end user, and region.

ENT Devices Market by Product

Based on the product, the global ENT devices market is segmented into diagnostic devices, surgical devices, hearing aids, image-guided surgery systems, and other products.

The hearing aids segment will likely dominate the market during the forecast period. A hearing aid is a small electronic device worn behind or in the ear. It amplifies some sounds so that a person with hearing loss may listen, converse, and participate in daily activities to a greater extent. People using hearing aids may hear more clearly in calm and loud environments. Hearing aids are most helpful for those with hearing loss brought on by damage to the inner ear's tiny sensory cells to enhance hearing and speech comprehension. Moreover, as the number of people with hearing loss rises, so does the need for these devices. By 2050, when it is anticipated that approximately 2.5 billion people will have some degree of hearing loss, at least 700 million individuals will need hearing rehabilitation, according to World Health Organization research from April 2021. Over 1 billion young individuals run the danger of suffering permanent, avoidable hearing damage as a result of their risky listening habits. 

Additionally, with the expansion of technology, there will likely be a significant increase in demand for hearing aids. Widex received recognition at the CES 2019 Best of Innovation Awards ceremony for its WIDEX EVOKETM fitness, sports, and biotech product line, which uses WIDEX ENERGY CELL technology. It is a hearing aid with no batteries. As a result, there will be a greater need for hearing aids, accelerating market expansion.

However, it is projected that increasing product releases by the major industry players will drive market expansion. For instance, Oticon, Inc. increased the number of hearing aid models available in February 2022 so that even more people with hearing loss might benefit from Oticon's cutting-edge BrainHearing technology. The updates include two new Oticon More miniBTE types and two new hearing aid families, catering to consumers who want compact, covert, behind-the-ear (BTE) choices.

ENT Devices Market by End User

Based on the end user, the global ENT devices market is segmented into hospitals, ENT clinics, and other end users.

The hospital segment is likely to dominate the market in the forecasted period. Higher demand for patients in hospitals is ensured by a better supply of skilled surgeons who can carry out challenging and even delicate diagnostic procedures. A large selection of state-of-the-art ENT equipment is also available at these institutions, which gives medical professionals more precision during operations and diagnostic procedures and influences patient choice. Global governments' growing efforts to improve hospital infrastructure significantly stimulate the segment's growth. The American government announced an expenditure of more than US$ 110 million for assisting rural hospitals back in October 2022.

ENT Devices Market by Region

Based on the region, the global ENT devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The ENT devices market is anticipated to be dominated by North America with 35.3% in 2022, which is anticipated to maintain a similar pattern during the projected period with minimal variation. The majority of market participants are headquartered in North America, where there is a high prevalence of END diseases and a general understanding of the benefits of adopting ENT device solutions, both of which are anticipated to be key growth drivers for the region's industry under study. For instance, one in eight Americans (13 percent, or 30 million) who are 12 years of age or older have hearing loss in both ears, according to a March 2021 study from the National Institute of Deafness and Other Communication Disorders of the United States1. Around 2% of individuals between 45 and 54 have hearing loss. The incidence increases to 8.5% for those 55 to 64. Additionally, ENT problems, including laryngeal cancer and hearing loss, are becoming more common due to an aging population.

During the projected period, the market in Asia Pacific is anticipated to develop at the quickest rate. The need for ENT devices is being fueled by the older population's increasing frequency of illnesses connected to the ears, nose, and throat. The World Health Organization predicts that between 2015 and 2050, the percentage of people over 60 will double, from 12% to 22%. Around 80% of the world's older adults will reside in low- and middle-income countries. Asia Pacific is predicted to expand fastest in the upcoming years. Additionally, In the coming years, demand for ENT diagnostic equipment is expected to increase significantly in China. End-user hospital procurement was the primary driver of over 70% of China medical device expansion. Chinese vendors compete heavily in low-end consumer goods, including wheelchairs, hearing aids, dentures, and other products. However, throughout the projection period, demand for premium consumables, such as diagnostic imaging and endoscopy, is anticipated to increase.

ENT devises Market Competitive Landscape

Some of the prominent market players in the global ENT devices market include, 

• American Hearing Systems Inc.
• Atos Medical
• Karl Storz
• Cochlear Ltd
• Pentax Medical
• InHealth Technologies
• Medtronic PLC
• GN Store Nord A/S
• Demant A/S
• Sonova
• Ambu A/S

ENT devises Market Strategic Development

• In February 2022, the NuVentTM Eustachian tube dilation balloon was approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic, obstructive Eustachian Tube Dysfunction; according to Medtronic plc., surgeons can provide therapy in an outpatient or office environment thanks to the NuVentTM balloon. Because of the flexible balloon part, it may be placed according to the patient's anatomy.
• In September 2021, Acclarent, Inc., announced the U.S. launch of its first-ever AI-powered ENT technology. This system is intended to streamline surgical planning and offer real-time feedback during ENT navigation procedures. With the help of a machine learning algorithm, the new software package, which includes TruSegTM and TruPathTM for use with the TruDi® Navigation System, offers accurate and effective image-guided preoperative planning and navigation for ENT operations, including endoscopic sinus surgery.

Frequently Asked Questions About This Report